Phase two CD19-antibody-drug conjugate trial demonstrates promise for aggressive lymphoma
MUSC Hollings Cancer Center (USA) was one of 28 clinical sites around the world that…
Browsing: Lymphoma
CNIO researchers discover a new pathway to tackle follicular lymphoma
For their own benefit and to grow beyond control, tumours manipulate cell signals to make…
Researchers discover a novel class of drugs that may help treat a deadly type of lymphoma
A new class of drugs that inhibits a “master switch” involved in the vast majority…
EHA 2021: Clinical trial efficacy of CAR-T therapy in patients with diffuse large B-cell lymphoma Is mirrored in the real world
DESCAR-T is the French national registry for patients treated with commercial chimeric antigen receptor (CAR)-T…
ASCO 2021: PET scans following initial treatment help many patients with bulky early-stage Hodgkin lymphoma avoid radiotherapy
Many early-stage patients with bulky classic Hodgkin lymphoma (cHL) can avoid radiotherapy treatment and still…
NK cells with bispecific antibody show activity against lymphoma cells
Preclinical study supports clinical trial of cord blood-derived natural killer cells with Affimed’s AFM13 as…
Protein found to control drivers of normal growth and cancer
Researchers have found a long-sought enzyme that prevents cancer by enabling the breakdown of proteins…
New CAR T approach minimises resistance, helps avoid relapse in non-Hodgkin’s B-cell lymphoma
Early results from a new, pioneering chimeric antigen receptor (CAR) T cell immunotherapy trial led…
AACR 2021: Copanlisib-rituximab combination cuts lymphoma progression or death by nearly half in CHRONOS-3 trial
A combination of copanlisib and rituximab led to a 48 percent reduction in the risk…
Excellent outcomes reported for first targeted therapy for paediatric Hodgkin lymphoma
Scientists are reporting results of the first frontline clinical trial to use targeted therapy to…